Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite-size pieces to help you stay on top of the field. Co-hosts Ute Burkhardt and Nathan Suek help listeners understand the implications behind new discoveries and invite renowned experts in the field to share their insights.
In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/
Thanks for listening! Let’s stay in touch:
In this first episode, our co-hosts talk about their background in immunology and what led them to it.
GUEST: Ed Fritsch. PhD, presidential fellow at the Dana-Farber, co-author of "Molecular Cloning: A Laboratory Manual", and co-founder of ACIR.
Thanks for listening! Let’s stay in touch:
Introducing "Immunotherapy Talks".
Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite size pieces to help you stay on top the field.
Thanks for listening! Let’s stay in touch:
